Investors
Financial targets and their archievements
As long-term financial goals until the end of 2024, Terveystalo has 5 percent annual revenue growth through organic growth and acquisitions and, in terms of profitability, an adjusted EBITA margin of 12 percent in 2025. Terveystalo published its updated financial targets for 2025–2029 in December 2024.
Financial targets until the end of 2024
| Growth | Profitability | Capital structure | Dividend | |
|---|---|---|---|---|
| Target | Annual revenue growth of at least 5 percent through organic growth and acquisitions | Adjusted EBITA margin of at least 12 percent in 2025 | The net debt/adjusted EBITDA ratio must be 3.5x or less. However, indebtedness may temporarily exceed the target level, such as in conjunction with acquisitions. | The target is to distribute a minimum of 40 percent of net profit as dividends annually. However, the dividend proposal must take into account Terveystalo’s long-term development potential and financial position. |
| Results in 2023 | Terveystalo’s revenue grew by 2.2% to EUR 1,286.4 million. | Terveystalo’s EBITA grew by 19.4% to EUR 125.6 million representing 9.8% of revenue. | Net debt/adjusted EBITDA was 3.0 at the end of 2023. | The Board of Directors proposes that a dividend of EUR 0.30 per share be paid for the financial year 2023. This represents 190.9% of the net result and 63.8% of the adjusted net result for the financial period. |
Financial targets 2025–2029
Profitable growth:
- EPS to grow on average by 10% p.a.
- We expect faster earnings per share growth in 2025, as fewer items affecting comparability are expected
Moderate leverage ratio:
- Net debt to EBITDA not to exceed 2.5x
- Indebtedness may temporarily surpass the target level, particularly in conjunction with acquisitions
Attractive dividends:
- At least 80% of net result to be distributed as dividends
- The dividend proposal must consider the company's long-term potential and financial status